The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.
March 23rd 2025
The systemic immune response index outperformed other inflammatory markers in predicting chronic obstructive pulmonary disease (COPD).
Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.
HFNC May Improve AECOPD Prognosis Better Than Conventional Therapy
Study Indicates ICS May Reduce New Cardiac Events in Patients With COPD
Review Finds Sarcopenia in COPD Drives Poorer Clinical Outcomes